Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06894381

Characteristics and Results of Patients Treated by Therapeutic Intensification

Characteristics and Results of Patients Treated by Therapeutic Intensification Followed by Autograft of Peripheral Stem Cells and Admitted to Intensive Care and Intensive Care: Single-center Retrospective Analysis

Status
Recruiting
Phase
Study type
Observational
Enrollment
24 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Many studies have focused on patients treated with allogeneic peripheral stem cell transplantation; few studies have until now been carried out to describe the characteristics and results of autografted patients and to attempt to determine possible prognostic factors. However, it is estimated that nearly 5% of autograft patients require MIR care. The investigators therefore wish to conduct a retrospective study including patients treated by therapeutic intensification followed by autograft of hematopoietic stem cells and admitted to the MIR department of the Hautepierre hospital of the University Hospitals of Strasbourg (HUS) within thirty days following initiation of chemotherapy.

Conditions

Timeline

Start date
2024-01-20
Primary completion
2025-12-01
Completion
2025-12-20
First posted
2025-03-25
Last updated
2025-03-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06894381. Inclusion in this directory is not an endorsement.

Characteristics and Results of Patients Treated by Therapeutic Intensification (NCT06894381) · Clinical Trials Directory